Javier Picado-Martinez

Barcelona, CT 08916, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 184 publications

Humanized FLT3 mice display enhanced tissue engraftment and support HIV‑1 persistence and rebound.

Humanized FLT3 mice display enhanced tissue engraftment and support HIV‑1 persistence and rebound.

Journal: bioRxiv : the preprint server for biology
Published: June 22, 2026

First-line dolutegravir/lamivudine penetrates lymph nodes and reduces HIV reservoirs comparably to triple therapy.

First-line dolutegravir/lamivudine penetrates lymph nodes and reduces HIV reservoirs comparably to triple therapy.

Journal: Research square
Published: June 12, 2026

Humanized FLT3 mice display enhanced tissue engraftment and support HIV‑1 persistence and rebound.

Humanized FLT3 mice display enhanced tissue engraftment and support HIV‑1 persistence and rebound.

Journal: Translational research : the journal of laboratory and clinical medicine
Published: May 21, 2026

HIV-1 envelope glycoprotein modulates CXCR4 clustering and dynamics on the T cell membrane.

HIV-1 envelope glycoprotein modulates CXCR4 clustering and dynamics on the T cell membrane.

Journal: eLife
Published: May 12, 2026

Increases in total HIV-1 nucleic acid in whole blood precede plasma RNA rebound during pediatric analytical treatment interruption.

Increases in total HIV-1 nucleic acid in whole blood precede plasma RNA rebound during pediatric analytical treatment interruption.

Journal: AIDS (London, England)
Published: December 13, 2025

Increases in total HIV-1 nucleic acid in whole blood precede plasma rna rebound during paediatric analytical treatment interruption.

Increases in total HIV-1 nucleic acid in whole blood precede plasma rna rebound during paediatric analytical treatment interruption.

Journal: AIDS (London, England)
Published: December 13, 2025

Pediatric long COVID is characterized by myeloid CCR6 suppression and immune dysregulation.

Pediatric long COVID is characterized by myeloid CCR6 suppression and immune dysregulation.

Journal: JCI insight
Published: October 09, 2025

Immune and senescence profiles associated with non-AIDS-defining cancer risk in people with HIV: a case-cohort study.

Immune and senescence profiles associated with non-AIDS-defining cancer risk in people with HIV: a case-cohort study.

Journal: Frontiers in immunology
Published: September 17, 2025

The power of ten in HIV remission: insights from hematopoietic stem cell transplantation.

The power of ten in HIV remission: insights from hematopoietic stem cell transplantation.

Journal: Current opinion in HIV and AIDS
Published: July 10, 2025

Strategies to Minimize Time From HIV Acquisition to ART Initiation: The Barcelona Early-cART Program.

Strategies to Minimize Time From HIV Acquisition to ART Initiation: The Barcelona Early-cART Program.

Journal: Open forum infectious diseases
Published: July 03, 2025

The imperative for increased investment for an HIV cure.

The imperative for increased investment for an HIV cure.

Journal: The lancet. HIV
Published: June 23, 2025

Long-term HIV-1 remission achieved through allogeneic haematopoietic stem cell transplant from a CCR5Δ32/Δ32 sibling donor.

Long-term HIV-1 remission achieved through allogeneic haematopoietic stem cell transplant from a CCR5Δ32/Δ32 sibling donor.

Journal: Nature microbiology
Published: June 23, 2025
Showing 1-12 of 184

Last Updated: 09/26/2026